38 filings
10-Q
2019 Q3
CNSP
Cns Pharmaceuticals Inc
20 Dec 19
Quarterly report
4:02pm
8-K
CNSP
Cns Pharmaceuticals Inc
22 Nov 19
CNS Pharmaceuticals Announces Full Exercise of Over-Allotment Option
8:00am
8-K
CNSP
Cns Pharmaceuticals Inc
14 Nov 19
CNS Pharmaceuticals Announces Closing Of Initial Public Offering of Common Stock
12:00am
4
CNSP
Cns Pharmaceuticals Inc
13 Nov 19
CNS Pharmaceuticals / Christopher Downs ownership change
5:12pm
3
CNSP
Cns Pharmaceuticals Inc
13 Nov 19
CNS Pharmaceuticals / Christopher Downs ownership change
5:11pm
3
zxinsrx97 8o2s9gkhje
8 Nov 19
CNS Pharmaceuticals / Waldemar Priebe ownership change
5:31pm
3
nwko 0lzhukznjn
8 Nov 19
CNS Pharmaceuticals / Jeffry R. Keyes ownership change
5:31pm
3
fnt7w
8 Nov 19
CNS Pharmaceuticals / Jerzy Gumulka ownership change
5:30pm
3
i065mar2kjk9vjc0
8 Nov 19
CNS Pharmaceuticals / Carl Anthony Evans ownership change
5:26pm
3
6ub3tudehge7vi3x3r8
8 Nov 19
CNS Pharmaceuticals / John M Climaco ownership change
5:25pm
3
rpen1 hxhgykf
8 Nov 19
CNS Pharmaceuticals / Andrzej Andraczke ownership change
5:24pm
424B4
xbv4b ia5g4cfyg
8 Nov 19
Prospectus supplement with pricing info
4:25pm
EFFECT
sgqpfhxv u9v2ew
8 Nov 19
Notice of effectiveness
12:15am
CERT
agcy60d0bhmgdzk5o5zq
6 Nov 19
Certification of approval for exchange listing
10:38am
8-A12B
uujqpdx
5 Nov 19
Registration of securities on exchange
12:15pm
CORRESP
23w ljxigvdys8sl
5 Nov 19
Correspondence with SEC
12:00am
CORRESP
eopdime1492uxrb364pk
5 Nov 19
Correspondence with SEC
12:00am
FWP
uunhs5qup5
11 Oct 19
Free writing prospectus
9:05pm
FWP
kc7rdfemr0jou6h5 65
10 Oct 19
Free writing prospectus
2:26pm